Annual report pursuant to Section 13 and 15(d)

EQUITY AND SHARE BASED COMPENSATION PLANS- Stock Options (Details)

v3.20.1
EQUITY AND SHARE BASED COMPENSATION PLANS- Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Feb. 01, 2020
Feb. 02, 2019
Feb. 03, 2018
Stock Options      
Number of Shares      
Outstanding at the beginning of the period (in shares) 1,252,072    
Granted (in shares) 3,258,797    
Forfeited (in shares) (415,327)    
Expired (in shares) (142,955)    
Outstanding at the end of the period (in shares) 3,952,587 1,252,072  
Vested and expected to vest at end of the period (in shares) 3,814,766    
Exercisable at the end of the period (in shares) 830,093    
Weighted-Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) $ 23.64    
Granted (in dollars per share) 7.42    
Forfeited (in dollars per share) 10.44    
Expired (in dollars per share) 26.98    
Outstanding at the end of the period (in dollars per share) 11.53 $ 23.64  
Vested and expected to vest at end of the period (in dollars per share) 11.68    
Exercisable at the end of the period (in dollars per share) $ 24.59    
Additional disclosures      
Outstanding at the end of the period, Remaining Contractual Term (in years) 8 years 6 months    
Vested and excepted to vest, Weighted-Average Remaining Contractual Term (in years) 8 years 4 months 24 days    
Exercisable at the end of the period, Remaining Contractual Term (in years) 5 years 9 months 18 days    
Weighted-average grant date fair value of stock options granted (in dollars per share) $ 2.98 $ 10.29 $ 3.86
Assumptions used to value stock options      
Intrinsic value of option exercised   $ 1,700 $ 100
Stock Appreciation Rights ("SARs")      
Number of Shares      
Granted (in shares) 414,476    
Outstanding at the end of the period (in shares) 414,476    
Vested and expected to vest at end of the period (in shares) 414,476    
Weighted-Average Exercise Price      
Granted (in dollars per share) $ 7.62    
Outstanding at the end of the period (in dollars per share) 7.62    
Vested and expected to vest at end of the period (in dollars per share) $ 7.62    
Additional disclosures      
Outstanding at the end of the period, Remaining Contractual Term (in years) 9 years 2 months 12 days    
Vested and excepted to vest, Weighted-Average Remaining Contractual Term (in years) 9 years 2 months 12 days    
Weighted-average grant date fair value of stock options granted (in dollars per share) $ 3.01    
Assumptions used to value stock options      
Dividend yield (as a percent) 0.00%    
Stock Options And Stock Appreciation Rights ("SARs")      
Assumptions used to value stock options      
Risk-free interest rate (as a percent) 2.35% 2.70% 1.75%
Expected lives (in years) 5 years 5 years 5 years
Dividend yield (as a percent) 4.09% 4.21% 4.69%
Expected volatility (as a percent) 62.65% 56.55% 55.12%
Intrinsic value of option exercised $ 0    
Unrecognized compensation cost      
Unrecognized compensation cost, non-vested awards $ 8,300    
Compensation recognition period, non-vested awards 1 year 6 months